Brian Mueller - 15 Mar 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
15 Mar 2022
Transactions value $
-$193,187
Form type
4
Filing time
17 Mar 2022, 21:38:25 UTC
Previous filing
07 Feb 2022
Next filing
06 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +11K +37.16% $0.00 40.7K 15 Mar 2022 Direct F1
transaction BMRN Common Stock Tax liability -$146K -1.87K -4.58% $78.27 38.9K 15 Mar 2022 Direct
transaction BMRN Common Stock Tax liability -$47K -582 -1.5% $80.72 38.3K 16 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Award $0 +26.5K $0.00 26.5K 15 Mar 2022 Common Stock 26.5K $78.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on March 15, 2022. Price not applicable.
F2 Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.